-
1
-
-
0031941423
-
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
-
DOI 10.1038/nm0398-328
-
Nestle FO, Alijagic S, Gilliet M et al (1998) Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 4: 328-332 (Pubitemid 28144092)
-
(1998)
Nature Medicine
, vol.4
, Issue.3
, pp. 328-332
-
-
Nestle, F.O.1
Alijagic, S.2
Gilliet, M.3
Sun, Y.4
Grabbe, S.5
Dummer, R.6
Burg, G.7
Schadendorf, D.8
-
2
-
-
0033405438
-
Vaccination with Mage-3A1 peptide-pulsed nature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
-
DOI 10.1084/jem.190.11.1669
-
Thurner B, Haendle I, Roder C et al (1999) Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 190:1669-1678 (Pubitemid 30002348)
-
(1999)
Journal of Experimental Medicine
, vol.190
, Issue.11
, pp. 1669-1678
-
-
Thurner, B.1
Haendle, I.2
Roder, C.3
Dieckmann, D.4
Keikavoussi, P.5
Jonuleit, H.6
Bender, A.7
Maczek, C.8
Schreiner, D.9
Von Den Driesch, P.10
Brocker, E.B.11
Steinman, R.M.12
Enk, A.13
Kampgen, E.14
Schuler, G.15
-
3
-
-
33744941816
-
Therapeutic dendritic cell vaccination of patients with renal cell carcinoma
-
DOI 10.1016/j.eururo.2006.03.061, PII S0302283806004593
-
Berntsen A, Geertsen PF, Svane IM (2006) Therapeutic dendritic cell vaccination of patients with renal cell carcinoma. Eur Urol 50:34-43 (Pubitemid 43850125)
-
(2006)
European Urology
, vol.50
, Issue.1
, pp. 34-43
-
-
Berntsen, A.1
Geertsen, P.F.2
Svane, I.M.3
-
4
-
-
68849107068
-
Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors
-
Suminoe A, Matsuzaki A, Hattori H et al (2009) Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors. Pediatr Transplant 13:746-753
-
(2009)
Pediatr Transplant
, vol.13
, pp. 746-753
-
-
Suminoe, A.1
Matsuzaki, A.2
Hattori, H.3
-
5
-
-
39149136228
-
Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival - A report from the children's oncology group
-
DOI 10.1200/JCO.2008.14.0095
-
Meyers PA, Schwartz CL, Krailo MD et al (2008) Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival-a report from the Children's Oncology Group. J Clin Oncol 26:633-638 (Pubitemid 351264359)
-
(2008)
Journal of Clinical Oncology
, vol.26
, Issue.4
, pp. 633-638
-
-
Meyers, P.A.1
Schwartz, C.L.2
Krailo, M.D.3
Healey, J.H.4
Bernstein, M.L.5
Betcher, D.6
Ferguson, W.S.7
Gebhardt, M.C.8
Goorin, A.M.9
Harris, M.10
Kleinerman, E.11
Link, M.P.12
Nadel, H.13
Nieder, M.14
Siegal, G.P.15
Weiner, M.A.16
Wells, R.J.17
Womer, R.B.18
Grier, H.E.19
-
6
-
-
53549127280
-
Nonresectable multiple lung metastases of highgrade osteosarcoma of the humerus: Stable after twelve years. A case report
-
Palmerini E, Staals EL, Ferrari S et al (2008) Nonresectable multiple lung metastases of highgrade osteosarcoma of the humerus: stable after twelve years. A case report. J Bone Joint Surg Am 90:2240-2244
-
(2008)
J Bone Joint Surg Am
, vol.90
, pp. 2240-2244
-
-
Palmerini, E.1
Staals, E.L.2
Ferrari, S.3
-
7
-
-
70349680756
-
Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma
-
Ribas A, Comin-Anduix B, Chmielowski B et al (2009) Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma. Clin Cancer Res 15:6267-6276
-
(2009)
Clin Cancer Res
, vol.15
, pp. 6267-6276
-
-
Ribas, A.1
Comin-Anduix, B.2
Chmielowski, B.3
-
8
-
-
0035576891
-
Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression
-
Geiger JD, Hutchinson RJ, Hohenkirk LF et al (2001) Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression. Cancer Res 61:8513-8519 (Pubitemid 33131133)
-
(2001)
Cancer Research
, vol.61
, Issue.23
, pp. 8513-8519
-
-
Geiger, J.D.1
Hutchinson, R.J.2
Hohenkirk, L.F.3
McKenna, E.A.4
Yanik, G.A.5
Levine, J.E.6
Chang, A.E.7
Braun, T.M.8
Mule, J.J.9
-
9
-
-
36849005123
-
Phase I study of tumor Ag-loaded IL-12 secreting semi-mature DC for the treatment of pediatric cancer
-
DOI 10.1080/14653240701589221, PII 782851694
-
Dohnal AM, Witt V, Hugel H et al (2007) Phase I study of tumor Ag-loaded IL-12 secreting semimature DC for the treatment of pediatric cancer. Cytotherapy 9:755-770 (Pubitemid 350226755)
-
(2007)
Cytotherapy
, vol.9
, Issue.8
, pp. 755-770
-
-
Dohnal, A.M.1
Witt, V.2
Hugel, H.3
Holter, W.4
Gadner, H.5
Felzmann, T.6
-
10
-
-
4344560470
-
Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer
-
DOI 10.1215/S1152851703000668
-
Caruso DA, Orme LM, Neale AM et al (2004) Results of a phase 1 study utilizing monocytederived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer. Neuro Oncol 6:236-246 (Pubitemid 39136507)
-
(2004)
Neuro-Oncology
, vol.6
, Issue.3
, pp. 236-246
-
-
Caruso, D.A.1
Orme, L.M.2
Neale, A.M.3
Radcliff, F.J.4
Armor, G.M.5
Maixner, W.6
Downie, P.7
Hassall, T.E.8
Tang, M.L.K.9
Ashley, D.M.10
-
11
-
-
0033759296
-
Dendritic cells infected with recombinant fowlpox virus vectors are potent and long-acting stimulators of transgene-specific class i restricted T lymphocyte activity
-
Brown M, Zhang Y, Dermine S et al (2000) Dendritic cells infected with recombinant fowlpox virus vectors are potent and long-acting stimulators of transgene-specific class I restricted T lymphocyte activity. Gene Ther 7:1680-1689
-
(2000)
Gene Ther
, vol.7
, pp. 1680-1689
-
-
Brown, M.1
Zhang, Y.2
Dermine, S.3
-
12
-
-
0034734639
-
Treatment of solid tumours in children with tumour-lysate-pulsed dendritic cells
-
Geiger J, Hutchinson R, Hohenkirk L et al (2000) Treatment of solid tumours in children with tumour-lysate-pulsed dendritic cells. Lancet 356: 1163-1165
-
(2000)
Lancet
, vol.356
, pp. 1163-1165
-
-
Geiger, J.1
Hutchinson, R.2
Hohenkirk, L.3
-
13
-
-
0036214287
-
Immunotherapy with autologous dendritic cells and tumor-specific synthetic peptides for synovial sarcoma
-
DOI 10.1097/00043426-200203000-00012
-
Matsuzaki A, Suminoe A, Hattori H et al (2002) Immunotherapy with autologous dendritic cells and tumor-specific synthetic peptides for synovial sarcoma. J Pediatr Hematol Oncol 24:220-223 (Pubitemid 34297567)
-
(2002)
Journal of Pediatric Hematology/Oncology
, vol.24
, Issue.3
, pp. 220-223
-
-
Matsuzaki, A.1
Suminoe, A.2
Hattori, H.3
Hoshina, T.4
Hara, T.5
-
14
-
-
77649123099
-
Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours
-
Ardon H, De Vleeschouwer S, Van Calenbergh F et al (2010) Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours. Pediatr Blood Cancer 54:519-525
-
(2010)
Pediatr Blood Cancer
, vol.54
, pp. 519-525
-
-
Ardon, H.1
De Vleeschouwer, S.2
Van Calenbergh, F.3
-
15
-
-
0034606349
-
Crosspriming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells
-
Berard F, Blanco P, Davoust J et al (2000) Crosspriming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J Exp Med 192:1535-1544
-
(2000)
J Exp Med
, vol.192
, pp. 1535-1544
-
-
Berard, F.1
Blanco, P.2
Davoust, J.3
-
16
-
-
28744456881
-
2 in chemokine and cytokine expression by MoDCs
-
DOI 10.1093/intimm/dxh335
-
Rubio MT, Means TK, Chakraverty R et al (2005) Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs. Int Immunol 17:1561-1572 (Pubitemid 41754679)
-
(2005)
International Immunology
, vol.17
, Issue.12
, pp. 1561-1572
-
-
Rubio, M.T.1
Means, T.K.2
Chakraverty, R.3
Shaffer, J.4
Fudaba, Y.5
Chittenden, M.6
Luster, A.D.7
Sykes, M.8
-
17
-
-
33845937761
-
Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor
-
DOI 10.1016/j.jpedsurg.2006.09.008, PII S0022346806006531
-
Shilyansky J, Jacobs P, Doffek K et al (2007) Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor. J Pediatr Surg 42:54-61; discussion 61 (Pubitemid 46037713)
-
(2007)
Journal of Pediatric Surgery
, vol.42
, Issue.1
, pp. 54-61
-
-
Shilyansky, J.1
Jacobs, P.2
Doffek, K.3
Sugg, S.L.4
-
18
-
-
0036499224
-
Prostaglandins as modulators of immunity
-
DOI 10.1016/S1471-4906(01)02154-8, PII S1471490601021548
-
Harris SG, Padilla J, Koumas L et al (2002) Prostaglandins as modulators of immunity. Trends Immunol 23:144-150 (Pubitemid 34178297)
-
(2002)
Trends in Immunology
, vol.23
, Issue.3
, pp. 144-150
-
-
Harris, S.G.1
Padilla, J.2
Koumas, L.3
Ray, D.4
Phipps, R.P.5
-
19
-
-
55749116154
-
Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion
-
Chizzolini C, Chicheportiche R, Alvarez M et al (2008) Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood 112:3696-3703
-
(2008)
Blood
, vol.112
, pp. 3696-3703
-
-
Chizzolini, C.1
Chicheportiche, R.2
Alvarez, M.3
-
20
-
-
67649985180
-
Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFNgamma production by memory CD4+ T cells
-
Napolitani G, Acosta-Rodriguez EV, Lanzavecchia A et al (2009) Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFNgamma production by memory CD4+ T cells. Eur J Immunol 39:1301-1312
-
(2009)
Eur J Immunol
, vol.39
, pp. 1301-1312
-
-
Napolitani, G.1
Acosta-Rodriguez, E.V.2
Lanzavecchia, A.3
|